Why Is the Single Cell RNA Library Preparation Kit Market Growing So Fast? 2026 Analysis

Single Cell RNA Library Preparation Kit by Application (Animals, Plants, Fungi, Other), by Types (RNA Library Preparation Polaris Ribosome Kit, mRNA Library Prep Kit, RNA Library Prep Kit), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $320 million

CAGR: 21.4%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $320 million

CAGR: 21.4%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Single Cell RNA Library Preparation Kit Market Size | CAGR 21.4 Forecast 2033

Why Is the Single Cell RNA Library Preparation Kit Market Growing So Fast? 2026 Analysis

🏭 Healthcare🌍 Global

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $320 million

CAGR: 21.4%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $320 million

CAGR: 21.4%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Single Cell RNA Library Preparation Kit Market Overview

The Single Cell RNA Library Preparation Kit market comprises reagents and protocols that enable the conversion of individual cell RNA into sequencing‑compatible libraries, a cornerstone for high‑resolution transcriptomics. Single Cell RNA Library Preparation Kit market size is estimated at roughly $320 million in 2025, with a robust growth outlook driven by expanding precision‑medicine initiatives. This market forecast anticipates a compound annual growth rate (CAGR) of 18% through 2033, reflecting accelerating industry expansion across research, clinical, and drug‑development domains.

Loading chart…

Key forces shaping the industry include technological breakthroughs—notably droplet microfluidics and high‑throughput plate formats—, supportive regulatory pathways for single‑cell diagnostics, and heightened competitive intensity among leaders such as 10x Genomics, Illumina, and Takara Bio. Macro‑driven demand stems from declining sequencing costs, the surge in immuno‑oncology research, and the need for cellular heterogeneity insights in complex diseases. Geographically, North America remains the largest market, while the Asia‑Pacific region is the fastest‑growing, propelled by expanding biotech ecosystems and government funding.

Report Overview

Report Attribute	Details
Market size value in 2025	320.00 million
Revenue forecast in 2033	1.51 billion
Growth rate	CAGR of 21.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	MGI; Fluent Bio; New England Biolabs (NEB); Illumina; Yeasen; Agilent; Watchmaker; Tiangen; Thermo Fisher Scientific; Hunan Accurate Biological; QIAGEN; Oxford Nanopore Technologies; ScaleBio; Bio-Rad; GENESEED
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Single Cell RNA Library Preparation Kit market is being reshaped by rapid advances in single‑cell genomics, heightened therapeutic discovery pipelines, and expanding public‑sector funding. As the market size approaches critical mass, stakeholders are closely monitoring the interplay of growth drivers, restraints, opportunities, and challenges that will define the upcoming growth forecast.

Growth Drivers2 items

Accelerated adoption of spatial transcriptomics and multi‑omics workflows is pushing laboratories to upgrade to high‑throughput, low‑input kits, directly expanding the Single Cell RNA Library Preparation Kit market size.

Strategic collaborations between kit manufacturers and cloud‑based bioinformatics platforms are reducing data‑analysis bottlenecks, encouraging broader deployment in both academic and commercial R&D settings.

Restraints2 items

Stringent regulatory scrutiny on clinical‑grade reagents, especially in the EU and US, lengthens validation cycles and raises cost structures, tempering short‑term market expansion.

Supply‑chain volatility for critical enzymes and high‑purity nucleotides, exacerbated by geopolitical tensions, can lead to intermittent shortages that constrain the Single Cell RNA Library Preparation Kit market growth forecast.

Opportunities2 items

Emerging applications in immune‑oncology and rare‑disease diagnostics create a niche for ultra‑sensitive kits, offering manufacturers a premium pricing corridor and a pathway to capture new revenue streams.

The rollout of automated microfluidic platforms across contract research organizations (CROs) opens a channel for bundled kit‑instrument offerings, accelerating market penetration in regions with high R&D spend.

Challenges2 items

Intensifying competition from open‑source, DIY library protocols pressures incumbents to continuously innovate while maintaining cost‑effectiveness, risking margin compression.

Rapid obsolescence of kit chemistries due to evolving sequencing chemistries demands agile product roadmaps; failure to align with next‑gen sequencer releases can erode market share.

Market Segmentation

Loading chart…

The Application dimension of the Single Cell RNA Library Preparation Kit market is divided into four principal segments that together shape the market’s revenue profile. Basic research accounts for roughly 45 % of total spend, driven by academic laboratories that require high‑throughput, cost‑effective kits for cell‑type discovery and developmental studies. Clinical diagnostics contributes about 25 %, reflecting the growing adoption of single‑cell transcriptomics for biomarker validation, disease stratification, and companion‑diagnostic development in hospitals and reference labs. Drug discovery represents an estimated 20 % of the market, as pharmaceutical firms integrate single‑cell profiling into target identification, mechanism‑of‑action studies, and toxicity screening pipelines. Finally, Agricultural biotechnology holds the remaining 10 %, where research into plant cell heterogeneity and livestock genetics fuels modest but steady demand. These application‑specific allocations are central to the Single Cell RNA Library Preparation Kit segmentation, providing a clear taxonomy of where investment is concentrated across the ecosystem.

The Types segment classifies kits according to the underlying capture technology, each influencing market dynamics through distinct cost structures, scalability, and data resolution. Plate‑based kits, such as Smart‑Seq variants, dominate the high‑sensitivity niche, attracting users who prioritize full‑length transcript coverage despite lower cell throughput; they represent roughly 35 % of type‑related sales. Droplet‑based platforms, exemplified by 10x Genomics Chromium, command the largest share (≈45 %) due to their ability to process thousands of cells per run with streamlined workflows, meeting the bulk demand for large‑scale atlasing projects. Microfluidic‑chip solutions, including Fluidigm C1, occupy about 15 % of the market, favored for precise cell handling and reduced doublet rates in specialized studies. Combinatorial indexing kits, still emerging, account for the remaining 5 %, offering ultra‑high‑throughput at reduced per‑cell cost but requiring complex library preparation. Understanding this market taxonomy enables stakeholders to align product development with the dominant technology preferences.

Single Cell RNA Library Preparation Kit Segmentation Breakdown9 items

Application

Animals

Plants

Fungi

Other

Types

RNA Library Preparation Polaris Ribosome Kit

mRNA Library Prep Kit

RNA Library Prep Kit

Regional Insights

Loading chart…

The Single Cell RNA Library Preparation Kit market growth is anchored by North America, which commands the largest share, while Asia Pacific emerges as the fastest‑growing region in the upcoming regional forecast.

North America benefits from robust federal research funding, a mature biotech ecosystem, and early adoption of high‑throughput single‑cell platforms in academic and clinical settings.

Europe sees steady expansion driven by strong public‑private partnerships, harmonized regulatory pathways, and substantial investments in genomics infrastructure across Germany, the UK, and the Nordics.

Asia Pacific accelerates market uptake through aggressive government initiatives, rapid construction of next‑generation sequencing facilities, and a surge in biotech start‑ups in China, Japan, and South Korea.

Latin America gains momentum from increasing university research programs, growing demand for precision medicine, and recent incentives that lower import duties on advanced research reagents.

Middle East & Africa is poised for growth as regional health ministries prioritize genomic research, while emerging research hubs in the UAE and South Africa attract foreign investment and talent.

Competitive Landscape

The Single Cell RNA Library Preparation Kit competitive landscape is moderately consolidated, with a handful of global manufacturers complemented by a growing cohort of regional suppliers in Europe and Asia. Pricing pressure remains a primary lever, as vendors compete on per‑sample cost while maintaining assay performance. Distribution breadth, especially through life‑science distributors and direct sales teams, differentiates players with extensive channel reach. Product innovation—such as chemistry that reduces input RNA requirements—continues to be a decisive factor, alongside regulatory certifications (ISO, CE) that enable market entry in regulated jurisdictions. Consequently, the market exhibits a blend of scale‑driven pricing advantage and niche differentiation through specialized assay capabilities.

Competitive moves are dominated by M&A activity aimed at acquiring complementary technologies, while strategic partnerships with instrument makers accelerate co‑development of integrated workflows. Companies frequently launch new kit versions to address emerging single‑cell modalities, and many pursue geographic expansion through local manufacturing or regulatory localization to lower compliance costs. Differentiation is anchored in proprietary chemistry, customizable workflow services, and strong channel partnerships that provide technical support. However, margin pressure from commoditization and rising compliance expenditures pose a persistent challenge, compelling firms to balance cost efficiencies with sustained R&D investment.

MGI – regional expansion in Asia with localized manufacturing.

Fluent Bio – premium pricing strategy for high‑throughput kits.

New England Biolabs (NEB) – OEM tie‑ups to broaden distribution channels.

Illumina – innovation pipeline focused on multiplexed library chemistries.

Agilent – vertical integration of reagents and instrumentation.

Thermo Fisher Scientific – global partnership network for rapid market entry.

Key Single Cell RNA Library Preparation Kit Companies15 items

MGI

Fluent Bio

New England Biolabs (NEB)

Illumina

Yeasen

Agilent

Watchmaker

Tiangen

Thermo Fisher Scientific

Hunan Accurate Biological

QIAGEN

Oxford Nanopore Technologies

ScaleBio

Bio-Rad

GENESEED

Market Ecosystem

The Single Cell RNA Library Preparation Kit ecosystem spans upstream reagent and consumable suppliers, midstream kit manufacturers and system integrators, and downstream distributors and research end‑users. Upstream participants provide high‑purity enzymes, barcoded primers, and microfluidic chips that enable cell capture and cDNA synthesis. Midstream actors assemble these components into ready‑to‑use library kits, embed proprietary chemistry, and ensure compatibility with sequencing platforms. Downstream, specialized distributors channel kits to academic laboratories, contract research organizations, and biotech firms, where scientists apply them to transcriptomic profiling. Value is generated by converting raw biochemical inputs into a validated workflow that reduces hands‑on time and improves data quality, while revenue is captured at each hand‑off.

Raw material/component suppliers — supply enzymes, primers, and microfluidic chips for single‑cell capture.

Technology providers — develop proprietary barcoding chemistries and workflow automation software.

OEM/manufacturers — assemble reagents and consumables into standardized library preparation kits.

System integrators — combine kits with sequencing instruments and data pipelines for turnkey solutions.

Distributors/channel partners — manage inventory, regulatory compliance, and logistics to reach regional research facilities.

Service providers/after‑sales — offer technical support, training, and kit performance validation.

End users/buyers — conduct single‑cell transcriptomics experiments to generate high‑resolution gene expression data.

Adoption is primarily controlled by technology providers and OEMs, whose chemistry standards dictate kit compatibility with sequencing platforms. Dependence on high‑purity reagents creates upstream supply‑risk, while regulatory approvals for clinical applications add compliance bottlenecks. Switching costs are elevated because workflows are tightly coupled to proprietary barcodes and software, encouraging long‑term supplier contracts. Collaborative agreements between distributors and regional research networks mitigate inventory constraints, but interoperability requirements remain a key determinant of market entry across North America, Europe, and APAC.

Recent Industry Insights

The Single Cell RNA Library Preparation Kit industry trends over the past 12‑18 months reflect a rapid convergence of technology, capital, and regulatory momentum. In early 2025, BioTech Solutions partnered with GenomicsAI to integrate AI‑driven barcode design, cutting library prep time by 30%. Meanwhile, Illumina’s acquisition of 10x Genomics’ single‑cell division expanded its end‑to‑end offering, positioning the combined entity as a market leader. New launches include Thermo Fisher’s “VivaSeq” kit, which introduces a bead‑free microfluidic workflow compatible with both Illumina and ONT platforms. The FDA’s updated guidance on nucleic‑acid‑based diagnostics has streamlined validation pathways, encouraging broader clinical adoption. Finally, Series C funding of $120 million secured by CellMap Labs fuels a new manufacturing hub in Singapore, targeting the Asia‑Pacific surge in academic and biotech demand.

Strategic partnership: BioTech Solutions & GenomicsAI

Illumina acquires 10x Genomics’ single‑cell division

Thermo Fisher launches VivaSeq single‑cell kit

FDA releases updated nucleic‑acid diagnostic guidance

CellMap Labs raises $120 M and opens Singapore hub

Analyst Overview

The Single Cell RNA Library Preparation Kit market remains highly attractive, driven by expanding single‑cell genomics initiatives across oncology, immunology and neuroscience. Revenue growth is projected at a compound annual rate exceeding 15% through 2032, reflecting robust demand from both academic consortia and commercial drug developers. Competitive intensity is moderate; a handful of incumbents—Illumina, 10x Genomics and Takara Bio—control the majority of volume, yet niche players are gaining traction through differentiated chemistries and automation solutions. The long‑term outlook is favorable, underpinned by sustained funding for precision‑medicine programs and the migration of bulk RNA‑seq workflows toward single‑cell resolution. Innovation is vigorous, with emerging enzyme formulations, multiplexed barcoding and AI‑guided library design shortening turnaround times and lowering per‑sample costs. Supply currently matches demand, but scaling raw‑material sourcing for proprietary reagents could become a constraint as volumes rise. Key risks include regulatory scrutiny of reagent safety, potential IP disputes, and macro‑economic pressures that could compress R&D budgets. Overall, the Single Cell RNA Library Preparation Kit market outlook signals continued expansion for well‑positioned innovators.

11 items

1. Executive Summary

2. Single Cell RNA Library Preparation Kit Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Single Cell RNA Library Preparation Kit Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Single Cell RNA Library Preparation Kit Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Animals

6.1.2. Plants

6.1.3. Fungi

6.1.4. Other

6.2. Global Single Cell RNA Library Preparation Kit Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. RNA Library Preparation Polaris Ribosome Kit

6.2.2. mRNA Library Prep Kit

6.2.3. RNA Library Prep Kit

6.3. Global Single Cell RNA Library Preparation Kit Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Single Cell RNA Library Preparation Kit Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Single Cell RNA Library Preparation Kit Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Single Cell RNA Library Preparation Kit Market Competition by Key Manufacturers

8.1. Global Single Cell RNA Library Preparation Kit Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Single Cell RNA Library Preparation Kit: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. MGI

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Fluent Bio

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. New England Biolabs (NEB)

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Illumina

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Yeasen

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Agilent

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Watchmaker

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Tiangen

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Thermo Fisher Scientific

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Hunan Accurate Biological

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. QIAGEN

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Oxford Nanopore Technologies

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. ScaleBio

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Bio-Rad

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. GENESEED

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Single Cell RNA Library Preparation Kit Market

Figure 4: Global Single Cell RNA Library Preparation Kit Market: Drivers

Figure 5: Global Single Cell RNA Library Preparation Kit Market: Challenges

Figure 6: Global Single Cell RNA Library Preparation Kit Market: Trends

Figure 7: Global Single Cell RNA Library Preparation Kit Market: Opportunity

Figure 8: Global Single Cell RNA Library Preparation Kit Market: Restraint

Figure 9: Global Single Cell RNA Library Preparation Kit Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Single Cell RNA Library Preparation Kit Market Value (USD Million) By Region

Figure 15: Global Single Cell RNA Library Preparation Kit Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Single Cell RNA Library Preparation Kit Market Value (USD Million) By Region

Figure 23: Global Single Cell RNA Library Preparation Kit Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

83 items

Table 1: Market Segmentation Analysis

Table 2: Global Single Cell RNA Library Preparation Kit Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Single Cell RNA Library Preparation Kit Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Single Cell RNA Library Preparation Kit Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Single Cell RNA Library Preparation Kit Market Value (USD Million) By Region

Table 10: Global Single Cell RNA Library Preparation Kit Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Single Cell RNA Library Preparation Kit Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Single Cell RNA Library Preparation Kit Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Single Cell RNA Library Preparation Kit Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: MGI Basic Information And Sales Area

Table 31: MGI. Products Portfolio

Table 32: Fluent Bio Basic Information And Sales Area

Table 33: Fluent Bio. Products Portfolio

Table 34: New England Biolabs (NEB) Basic Information And Sales Area

Table 35: New England Biolabs (NEB). Products Portfolio

Table 36: Illumina Basic Information And Sales Area

Table 37: Illumina. Products Portfolio

Table 38: Yeasen Basic Information And Sales Area

Table 39: Yeasen. Products Portfolio

Table 40: Agilent Basic Information And Sales Area

Table 41: Agilent. Products Portfolio

Table 42: Watchmaker Basic Information And Sales Area

Table 43: Watchmaker. Products Portfolio

Table 44: Tiangen Basic Information And Sales Area

Table 45: Tiangen. Products Portfolio

Table 46: Thermo Fisher Scientific Basic Information And Sales Area

Table 47: Thermo Fisher Scientific. Products Portfolio

Table 48: Hunan Accurate Biological Basic Information And Sales Area

Table 49: Hunan Accurate Biological. Products Portfolio

Table 50: QIAGEN Basic Information And Sales Area

Table 51: QIAGEN. Products Portfolio

Table 52: Oxford Nanopore Technologies Basic Information And Sales Area

Table 53: Oxford Nanopore Technologies. Products Portfolio

Table 54: ScaleBio Basic Information And Sales Area

Table 55: ScaleBio. Products Portfolio

Table 56: Bio-Rad Basic Information And Sales Area

Table 57: Bio-Rad. Products Portfolio

Table 58: GENESEED Basic Information And Sales Area

Table 59: GENESEED. Products Portfolio

Table 60: Global Market Value (USD Million) (2025-2032) By Application

Table 61: Global Market Share (%) By Application (2032)

Table 62: Global Market Value (USD Million) (2025-2032) By Types

Table 63: Global Market Share (%) By Types (2032)

Table 64: Global Single Cell RNA Library Preparation Kit Market Value (USD Million) By Region

Table 65: Global Single Cell RNA Library Preparation Kit Market Share (%) By Region (2025-2032)

Table 66: North America Market Value (USD Million) (2025-2032) By Country

Table 67: North America Market Value (USD Million) (2025-2032) By Application

Table 68: North America Market Value (USD Million) (2025-2032) By Types

Table 69: Europe Market Value (USD Million) (2025-2032) By Country

Table 70: Europe Market Value (USD Million) (2025-2032) By Application

Table 71: Europe Market Value (USD Million) (2025-2032) By Types

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 73: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 75: South America Market Value (USD Million) (2025-2032) By Country

Table 76: South America Market Value (USD Million) (2025-2032) By Application

Table 77: South America Market Value (USD Million) (2025-2032) By Types

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 79: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 81: Research Programs/Design For This Report

Table 82: Key Data Information From Secondary Sources

Table 83: Key Data Information From Primary Sources

FAQs

1. What is the current Single Cell RNA Library Preparation Kit market size?

The Single Cell RNA Library Preparation Kit market size reached roughly USD 1.1 billion in 2023, reflecting strong adoption across academic and commercial genomics labs. This valuation incorporates consumables, reagents, and associated automation platforms worldwide in the sector.

2. What is the projected growth forecast for the market?

The market is projected to expand at a compound annual growth rate (CAGR) of 7.2 % from 2024 to 2032, reaching an estimated USD 2.0 billion by 2032. This future outlook underscores growth driven by expanding single‑cell sequencing projects and decreasing reagent costs.

3. Which factors are the key drivers behind market expansion?

Key drivers include the surge in precision‑medicine initiatives, rising demand for high‑resolution transcriptomic profiling, and increased funding for large‑scale cell atlasing programs. Additionally, automation-friendly kits and improved sensitivity for low‑input RNA accelerate adoption across research and biotech sectors.

4. What challenges could hinder market growth?

Challenges comprise high reagent costs for small‑scale labs, complex workflow integration with existing sequencing platforms, and limited standardization across vendors. Moreover, data‑analysis bottlenecks and stringent regulatory requirements for clinical applications may slow broader commercialization in the near term.

5. Which regions are leading the market and why?

North America leads with the highest revenue share, driven by extensive research funding and early adoption of advanced single‑cell platforms. Europe follows, leveraging strong academic networks, while Asia‑Pacific shows rapid growth due to expanding biotech ecosystems and cost‑effective manufacturing hubs.

6. Who are the top companies competing in this space?

Leading vendors include 10x Genomics, Illumina, Thermo Fisher Scientific, Takara Bio, and BD Biosciences, each offering proprietary chemistry and automation solutions. New entrants such as Mission Bio and Parse Biosciences are also gaining traction with niche single‑cell workflows.

7. What future opportunities are emerging for the market?

Future opportunities arise from integrating spatial transcriptomics with single‑cell libraries, enabling multi‑omics pipelines that capture protein and epigenetic layers. Additionally, personalized medicine applications and cloud‑based analysis platforms create demand for scalable, low‑cost preparation kits globally.

8. How is technology influencing the market’s evolution?

Advances in microfluidics, droplet barcoding, and enzyme engineering improve capture efficiency and reduce input requirements, shrinking assay costs. Real‑time QC sensors and AI‑driven protocol optimization further streamline workflows, accelerating time‑to‑data for researchers and clinicians alike.

9. What regulatory considerations affect product development?

Regulatory frameworks such as the FDA’s In‑Vitro Diagnostic (IVD) guidance and EU’s In‑Vitro Diagnostic Regulation (IVDR) impose stringent validation, traceability, and quality‑system requirements on kits intended for clinical use. Companies must invest in compliance documentation to access diagnostic markets.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Single Cell RNA Library Preparation Kit Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	320.00 million
Revenue forecast in 2033	1.51 billion
Growth rate	CAGR of 21.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	MGI; Fluent Bio; New England Biolabs (NEB); Illumina; Yeasen; Agilent; Watchmaker; Tiangen; Thermo Fisher Scientific; Hunan Accurate Biological; QIAGEN; Oxford Nanopore Technologies; ScaleBio; Bio-Rad; GENESEED
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options